The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.03 (27.273%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.125
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jul 2017 11:10

RNS Number : 4378M
Deltex Medical Group PLC
28 July 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DELTEX MEDICAL GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: MISSED DISCLOSURE DUE TO SHARES IN ISSUE CHANGE

3. Details of person subject to the notification obligationiv

Name

J O HAMBRO CAPITAL MANAGEMENT LIMITED

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27 JULY 2017

6. Date on which issuer notified (DD/MM/YYYY):

28 JULY 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.72%

0.00%

9.72%

313,115,807

Position of previous notification (if

applicable)

10.68%

0.00%

10.68%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0059337583

30,419,696

9.72%

SUBTOTAL 8. A

30,419,696

9.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

-

The number and % of voting rights held

-

The date until which the voting rights will be held

-

11. Additional informationxvi

.

 

 

Place of completion

J O HAMBRO CAPITAL MANAGEMENT, LONDON

Date of completion

28 JULY 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXPAELXEFF
Date   Source Headline
4th Jun 20197:00 amRNSHolding(s) in Company
22nd May 201911:59 amRNSResult of AGM
22nd May 20197:00 amRNSChairman's Statement to Annual General Meeting
13th May 20191:55 pmRNSHolding(s) in Company
13th May 20197:00 amRNSExercise of Options
3rd May 20191:57 pmRNSTurner Pope Investor Evening
1st May 20194:47 pmRNSAnnual Report and Notification of AGM
1st May 20193:16 pmRNSAnnual Report and Notification of AGM
25th Apr 20197:00 amRNSResults for the year ended 31 December 2018
10th Apr 201911:10 amRNSNotice of Annual Results
6th Feb 20197:00 amRNSHolding(s) in Company
5th Feb 20198:58 amRNSDirector Dealing
29th Jan 20194:11 pmRNSExercise of Options
25th Jan 20197:00 amRNSPre-close statement and trading update
26th Nov 20181:08 pmRNSChange of Auditor
26th Sep 20188:16 amRNSHolding(s) in Company
24th Sep 20187:00 amRNSInterim results
18th Sep 20187:00 amRNSNotice of Results
28th Aug 20187:00 amRNSDirector Dealing
23rd Aug 201812:50 pmRNSDirector Dealing
6th Aug 20184:45 pmRNSGrant of Options - Correction
6th Aug 20187:00 amRNSGrant of options
30th Jul 20189:05 amRNSDirector Dealing
27th Jul 201811:35 amRNSHolding(s) in Company
27th Jul 201810:52 amRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSPre-close Trading Update
20th Jun 201812:01 pmRNSResult of AGM
20th Jun 20187:00 amRNSChairman's Statement to Annual General Meeting
13th Jun 20187:00 amRNSDirectorate change: Appointment of new CEO
18th May 20187:00 amRNSPartial redemption of convertible loan note
17th May 20187:00 amRNSAnnual Report and Notification of AGM
10th May 20187:00 amRNSInvestor Event
9th May 20187:00 amRNSTrueVueTM Loops display launched on CardioQ-ODM+
9th May 20187:00 amRNSResults for the year ended 31 December 2017
25th Apr 20187:00 amRNSNotice of results and FEDORA trial update
7th Mar 20183:51 pmRNSHolding(s) in Company
1st Mar 20187:00 amRNSODM reduces postoperative complications by 75%
20th Feb 20187:00 amRNSCardioQ-ODM+ wins Paris Hospital System Tender
12th Feb 20189:30 amRNSDirector dealing and issue of equity
9th Feb 20181:10 pmRNSResult of General Meeting
9th Feb 201810:12 amRNSResult of Offer and Additional Allotment
24th Jan 20185:17 pmRNSPosting of Circular
23rd Jan 20183:00 pmRNSResult of Oversubscribed Placing
23rd Jan 20187:00 amRNSPlacing, Subscription and Offer
17th Jan 20187:00 amRNSMajor New US Hospital Account
5th Jan 20187:00 amRNSTrading Update
24th Oct 20177:00 amRNSUS launch of TrueVue(TM) system
3rd Oct 20177:00 amRNSNew US hospital account
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.